Last update 14 Nov 2024

CTx-648

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
PF-9363
Target
KAT6A x KAT6B
Mechanism
KAT6A inhibitors(lysine acetyltransferase 6A inhibitors), KAT6B inhibitors(lysine acetyltransferase 6B inhibitors)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication
Estrogen receptor positive breast cancer
Inactive Indication-
Originator Organization
Pfizer Inc.Pfizer Inc.
Active Organization
Pfizer Inc.Pfizer Inc.
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure

Molecular FormulaC20H20N4O6S
InChIKeyVNSQFPFWUAZOTQ-UHFFFAOYSA-N
CAS Registry2569009-58-9

Related

100 Clinical Results associated with CTx-648
Login to view more data
100 Translational Medicine associated with CTx-648
Login to view more data
100 Patents (Medical) associated with CTx-648
Login to view more data
1
Literatures (Medical) associated with CTx-648
01 Oct 2023Cell chemical biology
HATS off to KAT6A/B inhibitors: A new way to target estrogen-receptor-positive breast cancer
100 Deals associated with CTx-648
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Estrogen receptor positive breast cancerPreclinical
US
Pfizer Inc.Pfizer Inc.
08 Aug 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free